Press Releases

5G will accommodate dramatically more devices, media, and users. This will especially impact the Internet of Things, which will result in a huge increase in the amount of remote monitors and sensors that will allow patients to be tracked while on the go. The new level of patient-generated healthcare data will permit enhanced analysis of various conditions and diseases, which will support personalized medicine and improved outcomes.5G technology will also enable wireless carriers to offer prov

Cardiovascular Systems, Inc.  has initiated a voluntary recall of unused WIRION Embolic Protection Systems (WIRION) due to complaints of filter breakage during retrieval. CSI has informed all affected healthcare facilities to discontinue use of WIRION immediately and return unused product to CSI. The U.S. Food and Drug Administration (FDA) has also been notified. To date, CSI has received 9 complaints of filter breakage during retrieval. Filter breakage may result in device emb

Le Institut de Cancérologie de Lorraine , in collaboration with the Institut du Cancer Joliot Curie (Joliot Curie Cancer Institute) of Dakar and Cerba HealthCare Group has just completed research showing that some cancers caused by the human papillomavirus (HPV) can be diagnosed with a simple blood test. Building on the innovative CaptHPV technique, this research recently published in the journal Clinical Cancer Research * raises the prospect of a non-invasive approach to dia

Clinigence Holdings, Inc.a leading technology-enabled, risk-bearing population health management company, and Nutex Health, LLC (together with its affiliates, "Nutex"), one of the largest independent operators of micro-hospitals and hospital outpatient departments in the United States, today announced that they have signed a definitive merger agreement pursuant to which the companies will combine in a stock-for-stock merger transaction. Based in Houston, Texas and founded

Cybin Inc.  a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced it has awarded a grant for the first psychedelic treatment clinic at Lenox Hill Hospital, part of Northwell Health, to serve marginalized and underserved communities on the Upper East Side of Manhattan, New York. The program aims to become one of the first hospital-based clinical sites to offer psychedelic medicine in the United States. Lenox Hill Ho

Healthcare Triangle Inc., a leading provider of cloud and data transformation platform and solutions for healthcare and life sciences, is pleased to announce that Monument Health taps Healthcare Triangle to automate their document processing through readable.AI. Healthcare Triangle’s deep expertise in Artificial Intelligence (AI), Machine Learning (ML), and Natural Language Processing (NLP) has helped Monument Health turn their clinical data from disparate sources into actiona

athenahealth, Inc. a leading provider of cloud-based enterprise software solutions for medical groups and health systems nationwide, today announced it has entered into a definitive agreement to be jointly acquired by affiliates of Bain Capital and Hellman & Friedman for $17 billion. The purchase from Veritas Capital and Evergreen Coast Capital affirms athenahealth’s position as the largest and most innovative provider of cloud-based electronic medical record and physician practice

Montecito Medical, a premier owner of medical office properties throughout the U.S., has completed the acquisition of a medical building in West Springfield, Massachusetts, that includes an ophthalmic surgery center. The property, which offers 22,158 square feet of space, is leased to Eye and LASIK Center, a market-dominant specialty practice group. “We are very pleased for the opportunity to acquire this recently renovated medical building, and we are excited to ent

Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced Food and Drug Administration (FDA) clearance of its proprietary NEUROMARK™ Rhinitis Neurolysis Therapy™ (RNT). The clearance gives clinicians access to an in-office treatment designed to create lesions to disrupt the posterior nasal nerves, for patients with chronic rhinitis. Approximately one in four Americans suffer from chronic rhinitis1, a conditi

Calroy Health Sciences, a company dedicated to developing innovative natural solutions to optimize cardiovascular health, has announced it has been awarded a patent titled “Methods to Stabilize and Reverse Atherosclerotic Lesions by Sulfated Polysaccharides” for its cardiovascular support product Arterosil®. “The patent is a critical milestone as we establish the exceptional clinical value of Arterosil,” said Ed Hoyt, President and CEO of Calroy Health Sc